February 15 2018 - 3 great acquisition targets for Gilead Sciences

3 great acquisition targets for Gilead Sciences, Merck KGaA and Pfizer’s immunotherapy fails lung cancer trial, 3 tough questions for Amgen, and more

For banking news and anonymous forums, be sure to check out cafebanking.com